WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer

S Ripka(Universität Ulm), Patrick Michl(Heidelberg University)

Carcinogenesis

January 17, 2007

10.1093/carcin/bgl255

Cited by 172

Related Papers

The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI

|BMC Cancer|2017|226

CUTL1 Is Phosphorylated by Protein Kinase A, Modulating Its Effects on Cell Proliferation and Motility

|Journal of Biological Chemistry|2006|28

Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction

|JAMA Network Open|2024|13

New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting

|Gastroenterology|2021|5